Vanda's drug for rare disorder meets main trial goal

Vanda's drug for rare disorder meets main trial goal: (Reuters) - Vanda Pharmaceuticals Inc said a late-stage trial of its drug for treating a rare disorder affecting blind people met the main goal of showing improvement over a placebo